GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ibex Technologies Inc (TSXV:IBT) » Definitions » Price-to-Owner-Earnings

Ibex Technologies (TSXV:IBT) Price-to-Owner-Earnings : 9.00 (As of Jun. 09, 2024)


View and export this data going back to 1986. Start your Free Trial

What is Ibex Technologies Price-to-Owner-Earnings?

As of today (2024-06-09), Ibex Technologies's share price is C$1.44. Ibex Technologies's Owner Earnings per Share (TTM) ended in Jan. 2024 was C$0.16. It's Price-to-Owner-Earnings for today is 9.00.


The historical rank and industry rank for Ibex Technologies's Price-to-Owner-Earnings or its related term are showing as below:

TSXV:IBT' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 1.36   Med: 5.55   Max: 73.13
Current: 9

During the past 13 years, the highest Price-to-Owner-Earnings of Ibex Technologies was 73.13. The lowest was 1.36. And the median was 5.55.


TSXV:IBT's Price-to-Owner-Earnings is ranked better than
87.35% of 166 companies
in the Biotechnology industry
Industry Median: 33.7 vs TSXV:IBT: 9.00

As of today (2024-06-09), Ibex Technologies's share price is C$1.44. Ibex Technologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 was C$0.15. Therefore, Ibex Technologies's PE Ratio for today is 9.47.

As of today (2024-06-09), Ibex Technologies's share price is C$1.44. Ibex Technologies's EPS without NRI for the trailing twelve months (TTM) ended in was C$0.15. Therefore, Ibex Technologies's PE Ratio without NRI for today is 9.47.

During the past 13 years, Ibex Technologies's highest PE Ratio without NRI was 29.00. The lowest was 1.57. And the median was 8.25.


Ibex Technologies Price-to-Owner-Earnings Historical Data

The historical data trend for Ibex Technologies's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ibex Technologies Price-to-Owner-Earnings Chart

Ibex Technologies Annual Data
Trend Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 6.43 12.50 4.53 8.04

Ibex Technologies Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.35 55.63 8.04 7.46 7.00

Competitive Comparison of Ibex Technologies's Price-to-Owner-Earnings

For the Biotechnology subindustry, Ibex Technologies's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ibex Technologies's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ibex Technologies's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Ibex Technologies's Price-to-Owner-Earnings falls into.



Ibex Technologies Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Ibex Technologies's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=1.44/0.16
=9.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ibex Technologies  (TSXV:IBT) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Ibex Technologies Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Ibex Technologies's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Ibex Technologies (TSXV:IBT) Business Description

Traded in Other Exchanges
Address
5485 Pare Street, Suite 100, Montreal, QC, CAN, H4P 1P7
Ibex Technologies Inc is a company engaged in the production and sale of diagnostic products. It manufactures and markets enzymes for biomedical use, through its subsidiaries. It also manufactures and markets a series of arthritis assays that have applications in osteoarthritis research. It sells two product lines namely, Enzymes for in-vitro diagnostics and research, and Tests for osteoarthritis research. The group provides services like Filing and lyophilization of disposable diagnostic components, and Custom fermentation and purification of enzymes for diagnostic companies. Geographically, the firm sells its products in Canada, Germany, the U.S., the U.K., and other countries of which the majority of the revenue is generated from the U.S.

Ibex Technologies (TSXV:IBT) Headlines

No Headlines